<HTML>
<HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">
<DIV style="font-size: 10pt">
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>

<P style="font-size: 14pt" align="center"><B>UNITED STATES<BR>
SECURITIES AND
EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P style="font-size: 18pt" align="center"><B>FORM 8-K</B>

<P style="font-size: 12pt" align="center"><B>CURRENT REPORT<BR>
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934</B>

<P style="font-size: 10pt" align="center"><B>Date of Report (Date of earliest
event reported): April 7, 2009 (April 6, 2009)</B>


<P style="font-size: 24pt" align="center"><B>Lifevantage
Corporation<BR>
</B><FONT style="font-size: 10pt">(Exact name of registrant as
specified in its charter) </FONT>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="32%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="33%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="32%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>Colorado</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>000-30489</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>90-0224471</B></TD>
 </TR>
 <TR valign="top">
  <TD>(State or other Jurisdiction of Incorporation)</TD>
  <TD>&nbsp;</TD>
  <TD>(Commission File Number)</TD>
  <TD>&nbsp;</TD>
  <TD>(IRS Employer Identification No.)</TD>
 </TR>

</TABLE>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="49%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="49%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>11545 W. Bernardo Court,
Suite 301, San Diego, California <BR>
</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>92127</B></TD>
 </TR>
 <TR valign="top">
  <TD>(Address of Principal Executive Offices)</TD>
  <TD>&nbsp;</TD>
  <TD>(Zip Code)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="center">Registrant&#8217;s telephone number,
including area code: <B>(858) 312-8000</B>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="30%" border="0">

 <TR>
  <TD width="100%">&nbsp;</TD>
 </TR>
 <TR>
  <TD style="border-bottom: #000000 1px solid" nowrap><B>&nbsp;</B></TD>
 </TR>
 <TR>
  <TD nowrap>(Former name or former address if changed since last report.)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="left">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:

<P style="font-size: 10pt" align="left"><FONT face="Wingdings">o</FONT> Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)<BR>
<BR>
<FONT face="Wingdings">o</FONT> Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>



<DIV
style="margin-top: 10pt; font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
</DIV>

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="justify"><B>Item&nbsp;3.02 Unregistered Sales
of Equity Securities</B>

<P style="font-size: 10pt" align="justify">On April&nbsp;6, 2009, Lifevantage
Corporation (the &#8220;Company&#8221;) held the third and final closing of an
offering to accredited investors of shares of Common Stock and warrants to
purchase Common Stock (the &#8220;Offering&#8221;). The Company sold 4,460,000
shares of Common Stock of the Company at a purchase price of $0.20 per share
and issued warrants exercisable for shares of Common Stock of the Company in
the third closing of the Offering, for aggregate gross proceeds of $892,000 in
the third closing. The Company sold an aggregate of 17,500,000 shares of Common
Stock of the Company at a purchase price of $0.20 per share and issued warrants
exercisable for 17,500,000 shares of Common Stock of the Company in the
Offering, for aggregate gross proceeds of $3,500,000. The warrants sold in the
Offering have an exercise price of $0.50 per share and may be exercised at any
time following issuance during the three year exercise period.

<P style="font-size: 10pt" align="justify">The Company issued a warrant to
purchase 1,500,000 shares of Common Stock of the Company to Aspenwood Capital
as part of the consideration for services provided to the Company by Aspenwood
Capital in connection with the Offering. The warrant issued to Aspenwood
Capital is identical to the form of warrant issued by the Company in the
Offering.

<P style="font-size: 10pt" align="justify">The shares and warrants were offered
and sold in the Offering only to persons who meet the definition of
&#8220;accredited investor&#8221; set forth in Rule 501(a) of Regulation&nbsp;D
promulgated under the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), or to persons who are not &#8220;U.S. persons&#8221; as defined in
Regulation&nbsp;S under the Securities Act, pursuant to exemptions from
registration provided by Rule&nbsp;506 of Regulation&nbsp;D of the Securities
Act and Regulation&nbsp;S of the Securities Act.

<P style="font-size: 10pt" align="justify"><B>Item&nbsp;7.01 Regulation&nbsp;FD
Disclosure</B>

<P style="font-size: 10pt" align="justify">On April&nbsp;7, 2009, the Company
issued a press release entitled, &#8220;Aspenwood Capital Raises $3.5 Million
for LifeVantage Corporation&#8221;. The press release is attached as
Exhibit&nbsp;99.1 hereto, which is furnished under Item&nbsp;7.01 of this
report and shall not be deemed to be &#8220;filed&#8221; for purposes of
Section&nbsp;18 of the Securities Exchange Act of 1934 (the &#8220;Exchange
Act&#8221;) or otherwise subject to the liabilities of that section, nor shall
it be deemed incorporated by reference in any filing under the Securities Act
or the Exchange Act, regardless of any general incorporation language in such
filing.

<P style="font-size: 10pt" align="justify"><B>Item&nbsp;9.01 Exhibits</B>

<P style="font-size: 10pt; text-indent: 4%" align="justify">99.1 Press release,
dated April&nbsp;7, 2009, entitled, &#8220;Aspenwood Capital Raises $3.5
Million for LifeVantage Corporation&#8221;.

<P style="font-size: 10pt; text-indent: 4%" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="center"><B>SIGNATURES</B>

<P style="font-size: 10pt" align="justify">Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned thereunto duly authorized.

<P style="font-size: 10pt" align="justify">Date: April&nbsp;7, 2009

<P style="font-size: 10pt; margin-left: 45%" align="justify">LIFEVANTAGE
CORPORATION

<P style="font-size: 10pt; margin-left: 45%" align="justify">By:
<U>/s/ Bradford K. Amman&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><BR>
Bradford K. Amman<BR>
Chief Financial
Officer<BR>


<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="center"><B>EXHIBIT INDEX</B>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%"
border="0">
<!-- Begin Table Head -->

 <TR valign="bottom">
  <TD width="8%">&nbsp;</TD>
  <TD width="5%">&nbsp;</TD>
  <TD width="87%">&nbsp;</TD>
 </TR>
 <TR style="font-size: 10pt" valign="bottom">
  <TD style="border-bottom: #000000 1px solid" nowrap align="left"><B>Exhibit
No.</b></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid" nowrap
align="center"><b>Description</b></TD>
 </TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">99.1 </DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Press release, dated April&nbsp;7, 2009,
entitled, &#8220;Aspenwood Capital Raises $3.5 Million for LifeVantage
Corporation&#8221;.</TD>
 </TR>
<!-- End Table Body -->

</TABLE>
</DIV>

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">4
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "c83710e8vk.htm", "description": "FORM 8-K", "secsgml_size_bytes": 9799}]
{"company-data": {"conformed-name": "Lifevantage Corp", "cik": "0000849146", "assigned-sic": "2834", "irs-number": "841097796", "state-of-incorporation": "CO", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-30489", "film-number": "09738659"}, "business-address": {"street1": "6400 SOUTH FIDDLER", "street2": "SUITE 1750", "city": "ENGLEWOOD", "state": "CO", "zip": "80111", "phone": "720-488-1711"}, "mail-address": {"street1": "6400 SOUTH FIDDLER", "street2": "SUITE 1750", "city": "ENGLEWOOD", "state": "CO", "zip": "80111"}, "former-company": [{"former-conformed-name": "LIFELINE THERAPEUTICS, INC.", "date-changed": "20041019"}, {"former-conformed-name": "YAAK RIVER RESOURCES INC", "date-changed": "19920703"}, {"former-conformed-name": "ANDRAPLEX CORP", "date-changed": "19920406"}]}
Form 8-K
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): April 7, 2009 (April 6, 2009)
Lifevantage
Corporation
(Exact name of registrant as
specified in its charter)
Colorado
000-30489
90-0224471
(State or other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
11545 W. Bernardo Court,
Suite 301, San Diego, California
92127
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number,
including area code:
(858) 312-8000
(Former name or former address if changed since last report.)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 3.02 Unregistered Sales
of Equity Securities
On April 6, 2009, Lifevantage
Corporation (the "Company") held the third and final closing of an
offering to accredited investors of shares of Common Stock and warrants to
purchase Common Stock (the "Offering"). The Company sold 4,460,000
shares of Common Stock of the Company at a purchase price of $0.20 per share
and issued warrants exercisable for shares of Common Stock of the Company in
the third closing of the Offering, for aggregate gross proceeds of $892,000 in
the third closing. The Company sold an aggregate of 17,500,000 shares of Common
Stock of the Company at a purchase price of $0.20 per share and issued warrants
exercisable for 17,500,000 shares of Common Stock of the Company in the
Offering, for aggregate gross proceeds of $3,500,000. The warrants sold in the
Offering have an exercise price of $0.50 per share and may be exercised at any
time following issuance during the three year exercise period.
The Company issued a warrant to
purchase 1,500,000 shares of Common Stock of the Company to Aspenwood Capital
as part of the consideration for services provided to the Company by Aspenwood
Capital in connection with the Offering. The warrant issued to Aspenwood
Capital is identical to the form of warrant issued by the Company in the
Offering.
The shares and warrants were offered
and sold in the Offering only to persons who meet the definition of
"accredited investor" set forth in Rule 501(a) of Regulation D
promulgated under the Securities Act of 1933, as amended (the "Securities
Act"), or to persons who are not "U.S. persons" as defined in
Regulation S under the Securities Act, pursuant to exemptions from
registration provided by Rule 506 of Regulation D of the Securities
Act and Regulation S of the Securities Act.
Item 7.01 Regulation FD
Disclosure
On April 7, 2009, the Company
issued a press release entitled, "Aspenwood Capital Raises $3.5 Million
for LifeVantage Corporation". The press release is attached as
Exhibit 99.1 hereto, which is furnished under Item 7.01 of this
report and shall not be deemed to be "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934 (the "Exchange
Act") or otherwise subject to the liabilities of that section, nor shall
it be deemed incorporated by reference in any filing under the Securities Act
or the Exchange Act, regardless of any general incorporation language in such
filing.
Item 9.01 Exhibits
99.1 Press release,
dated April 7, 2009, entitled, "Aspenwood Capital Raises $3.5
Million for LifeVantage Corporation".
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned thereunto duly authorized.
Date: April 7, 2009
LIFEVANTAGE
CORPORATION
By:
/s/ Bradford K. Amman
Bradford K. Amman
Chief Financial
Officer
EXHIBIT INDEX
Exhibit
No.
Description
99.1
Press release, dated April 7, 2009,
entitled, "Aspenwood Capital Raises $3.5 Million for LifeVantage
Corporation".